To provide for a limitation on availability of funds for Department of Health and Human Services, National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases for fiscal year 2024.

This bill sets a spending cap of $2.03 billion for the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) within the National Institutes of Health (NIH) for fiscal year 2024. It directly affects the NIDDK by limiting its available funding to this specific amount, regardless of other appropriations. The provision is procedural, imposing a budgetary restriction without altering research programs or policies. No other NIH institutes or health programs are impacted by this specific funding limit.